GnRH antagonist cetrorelix prevents sexual maturation of peripubertal male rats

Experimental and Clinical Endocrinology and Diabetes

Volumn 108, Issue 5, 2000, Pages 358-363

  Roth, C ^a,b   Leonhardt, S ^a   Seidel, C ^a   Lakomek, M ^a   Wuttke, W ^a   Jarry, H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

GnRH antagonist; Hormone levels; Male rats; Puberty

Indexed keywords

CETRORELIX; FOLLITROPIN; GONADORELIN ANTAGONIST; GONADOTROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NONHUMAN; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RAT; SEXUAL MATURATION; TESTOSTERONE BLOOD LEVEL;

ANIMALS; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HORMONE ANTAGONISTS; HYPOTHALAMUS; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SEXUAL MATURATION; TESTIS; TESTOSTERONE;

EID: 0033856856     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-8129     Document Type: Article

References (28)

1. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K, Devroey P: Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 15: 526-531, 2000
2. Aslam H, Rosiepen G, Krishnamurthy H, Arslan M, Clemen G, Nieschlag E, Weinbauer GF: The cycle duration of the seminiferous epithelium remains unaltered during GnRH antagonist-induced testicular involution in rats and monkeys. J Endocrinol 161: 281-288, 1999
3. Behre HM, Klein B, Steinmeyer E, McGregor GP, Voight K, Nieschlag E: Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men. J Clin Endocrinol Metab 75: 393-398, 1992
4. Behre HM, Kliesch S, Pühse G, Reissmann T, Nieschlag E: High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle-stimulating hormone, and testosterone in normal men. J Clin Endocrinol Metab 82: 1403-1408, 1997
5. Bokser L, Srkalovic G, Szepeshazi K, Schally AV: Recovery of pituitary-gonadal function in male and female rats after prolonged administration of a potent antagonist of luteinizing hormone-releasing hormone (SB-75). Neuroendocrinology 54: 136-145, 1991
6. Bourguignon JP, Franchimont P: Puberty-related increase in episodic LHRH release from rat hypothalamus in vitro. Endocrinology 114: 1941-1943, 1984
7. Bourguignon JP, Gerard A. Franchimont P: Maturation of the hypothalamic control of pulsatile gonadotropin-releasing hormone secretion at onset of puberty: II. Reduced potency of an inhibitory autofeedback. Endocrinology 127: 2884-2890, 1990
8. Comaru-Schally AM, Brannan W, Schally AV, Colcolough M, Monga M: Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia. J Clin Endocrinol Metab 83: 3826-3831, 1998
9. Emons G, Schulz KD: Primary and salvage therapy with LH-RH analogues in ovarian cancer. Recent Results Cancer Res 153: 83-94, 2000
10. Felberbaum R, Reissmann T, Kupker W, Al-Hasani S, Bauer O, Schill T, Zoll C, Diedrich C, Diedrich K: Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages. J Assist Reprod Genet 13: 216-222, 1996
11. Feleder C, Jarry H, Leonhardt S, Moguilevsky JA, Wuttke W: Evidence to suggest that gonadotropin-releasing hormone inhibits its own secretion by affecting hypothalamic amino acid neurotransmitter release. Neuroendocrinol 64: 298-304, 1996
12. Haviv F, Bush EN, Knittle J, Greer J: LHRH antagonists. Pharm Biotechnol 11: 131-149, 1998
13. Johnson ES, Gendrich RL, White WF: Delay of puberty and inhibition of reproductive processes in the rat by a gonadotropin-releasing hormone agonist analog. Fertil Steril 27: 853-860, 1976
14. Lamharzi N, Schally AV, Koppan M: Luteinizing hormone-releasing hormone (LH-RH) antagonist cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors. Regul Pept 77: 185-192, 1998
15. Landymore KM, Wilkinson M: Chronic treatment with [D-Ala6, des Gly-NH2(10)]-LHRH ethylamide reversibly delays puberty in the female rat. Can J Physiol Pharmacol 62: 853-855, 1984
16. Lin Y, Kahn JA, Hillensjo T: Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?. Hum Reprod 14: 885-888, 1999
17. Morale MC, Batticane N, Bartoloni G, Guarcello V, Farinella Z, Galasso MG, Marchetti B: Blockade of central and peripheral luteinizing hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH-antagonist inhibits the morphofunctional development of the thymus and maturation of the cell-mediated and humeral immune responses. Endocrinology 128: 1073-1085, 1991
18. Oostdijk W, Drop SL, Odink RJ, Hummerlink R, Partsch CJ, Sippell WG: Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group. Acta Paediatr Scand Suppl 372: 39-45, 1991
19. Partsch CJ, Peter M, Sippell WG: Leuprorelindepot zur Behandlung der progressiven Pubertas praecox vera. Monatsschr Kinderheilkd 147: 638-647, 1999
20. Partsch CJ, Weinbauer GF, Schlatt S, Schiedermaier U, Schönau E, Sippell WG, Nieschlag E: Differential effects of GnRH agonist and GnRH antagonist in the suppression of puberty in cynomolgus monkeys. Horm Res 44 (Suppl 1): 30, 1995
21. Pescovitz OH, Barnes KM, Cutler GB Jr.: Effect of deslorelin dose in the treatment of central precocious puberty. J Clin Endocrinol Metab 72: 60-64, 1991
22. Phillips A, Hahn DW, McGuire JL, Ritchie D, Capetola RJ, Bowers C, Folkers K: Evaluation of the anaphylactoid activity of a new LHRH antagonist. Life Science 43: 883-888, 1988
23. Pinski J, Lamharzi N, Halmos G, Groot K, Jungwirth A, Vadillo-Buenfil M, Kakar SS, Schally AV: Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats. Endocrinology 137: 3430-3436, 1996
24. Plosker GL, Brogden RN: Leuprorelin - A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders. Drugs 48: 930-967, 1994
25. Reissmann T, Felberbaum R, Diedrich K, Engel J, Comaru-Schally AM, Schally AV: Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview. Hum Reprod 10: 1974-1981, 1995
26. Roth C, Leonhardt S, Theiling K, Lakomek M, Jarry H, Wuttke W: Ontogeny of the GnRH-, glutaminase- and glutamate decarboxylase-gene expression in the hypothalamus of female rats. Dev Brain Res 110: 105-114, 1998
27. Sippell WO, Partsch CJ, Hümmelink R, Lorenzen F: Long-term therapy with delayed-action LHRH-agonist decapeptyl depot in girls with precocious puberty. Results of an international multicenter study. Gynäkologe 24: 108-113, 1991
28. Wildt L, Marshall G, Knobil E: Experimental induction of puberty in the infantile female rhesus monkey. Science 207: 1373-1375, 1980